Additionally, we categorized the 57 cancer cell lines from the Gboxin sensitivity screen into five groups based on their sensitivities, illustrating a positive correlation between the expression of CKMT1A, CKMT1B, and CKB and the cell's sensitivity to Gboxin treatment (Figure 1C–F). This evidence concerns the gene CKMT1B and cancer.